Loading
Cardiovascular Disease / Cardiovascular Diseases · Journal article
Gut Microbes · August 21, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a methodological proof-of-concept study that developed the BIOCARD framework to detect intervention-associated changes in fecal bile acids, lipids, and metabolites within a 10-week caregiver–child nutritional intervention trial. The authors report that traditional clinical indicators showed limited sensitivity, whereas fecal multi-omics revealed intervention differences, particularly in children; however, the study is exploratory, lacks independent validation, and does not assess hard cardiovascular outcomes.
Randomized controlled trial with exploratory multi-omics analysis. Caregiver–child participants in a Food is Medicine trial; setting and specific eligibility criteria not fully detailed in excerpt. Intervention: Multicomponent garden-based intervention (SHA) including coordinated nutrition education, hands-on harvesting, culinary instruction, and caregiver-focused counseling. Compared with: Education-only control group (MSP). Ohio State University and affiliated institutions; specific multicenter details not provided in truncated text.
Traditional clinical indicators showed limited sensitivity for detecting intervention-related differences in this population Fecal multi-omics analysis revealed intervention-associated differences in metabolites, lipids, and bile acids Children showed more apparent molecular variation than parents in response to the intervention
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The BIOCARD framework is presented as an exploratory molecular complement to conventional outcome measures in nutritional intervention research. Clinicians and researchers should recognize this as a methodological development requiring independent validation before clinical application; it does not yet change practice.
An exploratory methodological study developing a novel multi-omics framework in a single 10-week RCT; demonstrates proof-of-concept that fecal bile acids, lipids, and metabolites may complement traditional measures, but lacks independent validation and hard clinical outcomes.
As stated by the source record.
Quoted from the source exactly as published.
The BIOCARD framework is presented as an exploratory molecular complement to conventional outcome measures in nutritional intervention research. Clinicians and researchers should recognize this as a methodological development requiring independent validation before clinical application; it does not yet change practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality, particularly in under-resourced populations. Although nutritional interventions are important for CVD prevention, their outcomes are commonly evaluated using conventional clinical and behavioral indicators, which may not fully capture early molecular responses. In this study, we developed the BIOCARD framework, an exploratory fecal multi-omics platform integrating bile acids, lipids, and metabolites to evaluate intervention outcomes related to cardiovascular health. Fecal samples were collected from caregiver-child participants enrolled in a 10-week randomized controlled trial comparing a multicomponent garden-based intervention (SHA) with an education-only control group (MSP). Fecal polar metabolites, lipids, and bile acids were analyzed by UHPLC-HRMS-based approaches and integrated with conventional health indicators. Traditional clinical indicators in the present study showed limited sensitivity for detecting intervention-related differences. In contrast, fecal multi-omics analyzes revealed intervention-associated differences in metabolites, lipids, and bile acids, with children showing more apparent molecular variation than parents. Network analysis further revealed associations between selected molecular features and cardiovascular-related indicators, including blood pressure, body fat, skin carotenoids, and Healthy Eating Index scores. Together, these findings suggest that the BIOCARD framework may serve as an exploratory molecular approach to complement traditional outcome measures and improve the evaluation of nutritional interventions for cardiovascular health.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.